Burkholderia pyrrocinia CH-67 is a biocontrol bacterium with strong antifungal activity against several plant pathogenic fungi. Transposon mutagenesis was performed to identify the genes responsible for the antifungal activity of B. pyrrocinia CH-67. Of the 2,500 mutants tested using the Fulvia fulva spore screening method, a mutant deficient in antifungal activity, M208, was selected. DNA sequence analysis of the transposon-inserted region revealed that a gene encoding an adenylate kinase-related kinase was disrupted in M208. Antifungal activity was restored in M208 when a full-length adenylate kinase gene with its promoter was introduced in trans. The deduced amino acid sequence of adenylate kinase from CH-67 was 80% identical to that of B. cenocepacia MCO-3. Adenosine diphosphate supplementation or high levels of adenosine triphosphate and adenosine monophosphate together restored antifungal activity in M208, suggesting that adenylate kinase of B. pyrrocinia CH-67 is involved in antifungal activity expression.
Biological control of plant diseases is a good alternative strategy for plant fungal disease management. Several plant fungal diseases cause extensive crop damage worldwide, although various chemical fungicides have been developed to control the diseases (Farr et al., 1989) . While fungicides are effective in controlling plant diseases, environmental concerns and the development of resistance in the target fungal pathogens have reduced the utility of chemical fungicides. In addition, the demand for organic food is gradually increasing. For these reasons, biological control has received much attention (Andrews et al., 1992; Becker and Schwinn, 1993; Handelsman and Stabb, 1996) . Several studies have reported the effective control of fungal disease in the greenhouse using various microorganisms (Asaka and Shoda, 1996; Mao et al., 1998; McLoughlin et al., 1992; Roberts et al., 2005) . The microorganisms include fluorescent pseudomonads that produce antibiotics, such as phenazines (Mavrodi et al., 2006) , 2,4-diacetylphloroglucinol (Fenton et al., 1992; Keel et al., 1992) , pyrrolnitrin (ElBanna and Winkelmann, 1998; Hill et al., 1994) , pyoluteorin (Howell and Stipanovic, 1980; Kraus and Loper, 1995) , and siderophores (Dowling and O'Gara, 1994) . Bacillus species are also good biocontrol bacteria producing various antifungal compounds, such as lipopeptides (Ongena and Jacques, 2008) . For many of these organisms, gene clusters encoding biosynthetic pathways have been cloned and characterized (Ehling-Schulz et al., 2005; Loper et al., 2008) . Increased efficacy and potential in biological control through engineering of these gene clusters have also been documented (Romero-Tabarez et al., 2006; Rondon et al., 2004) .
Bacteria in the Burkholderia cepacia complex possess diverse beneficial properties, such as indole acetic acid production, nitrogen fixation, and antifungal compound production (Parker and Gurian-Sherman, 2001 ). These organisms can produce a large variety of antifungal compounds, such as cepacidine (Lee et al., 1994) , pyrrolnitrin (Jayaswal et al., 1993) , xylocandins (Meyers et al., 1987) , and siderophores (Sokol et al., 1992) . Most recently purified and identified antibiotic from Burkholderia contaminans with antibacterial and antifungal activity was occidiofungin, a unique antifungal glycolipopetide (Gu et al., 2011; Lu et al., 2009 ). Discovery of occidiofungin and its biosynthetic gene cluster brought some potential of new antimicrobial compound discovery from Burkholderia species. The B. cepacia complex includes interesting strains for fungal disease management (Santos et al., 2004) ; however, some strains in the complex are clinical pathogens that cause cystic fibrosis (Holmes et al., 1998) . Nevertheless, these strains can be effective biocontrol agents for Pythiuminduced damping-off and Aphanomyces-induced root rot of pea (King and Parke, 1993; Parke et al., 1991) , Botrytisinduced gray mold of apple (Janisiewicz and Roitman, 1988) , Sclerotinia sclerotiorum-induced sclerotinia wilt (McLoughlin et al., 1992) , and other fungal diseases. Recently, it was reported that accurate investigation of B. cepacia complex can discriminate clinical isolates from other beneficial bacteria (Mahenthiralingam et al., 2005) . B. pyrrocinia CH-67 is a promising biocontrol agent, belonging to the B. cepacia complex genomovar IX, which is not associated with clinical isolates (Lee et al., 2011) . B. pyrrocinia CH-67 exhibited effective disease control activity against tomato leaf mold, and Rhizoctonia-induced damping-off of crisphead lettuce and tomato plants (Lee et al., 2011) . So far, a few genetic elements responsible for the antimicrobial and antifungal activities of Burkholderia have been characterized. Strain CH-67 exhibits a diverse range of antifungal activities against plant pathogens and is effective in controlling leaf mold in tomato plants (Lee et al., 2011) .
In this study, transposon mutagenesis was used to obtain non-antagonistic mutants and the mutated genes were identified to analyze the antagonistic activity of B. pyrrocinia CH-67. The findings from this study provide important information on the gene encoding adenylate kinase which is responsible for antifungal metabolite production in B. pyrrocinia. 
Materials and Methods
Culture conditions and media. The bacterial strains and plasmids used in this study are listed in Table 1 . Nutrient broth (NB) was used to culture Burkholderia strains at 30°C. Escherichia coli cultures were routinely grown at 37°C in Luria-Bertani (LB) medium (Sambrook et al., 1989) . The fungal pathogen Fulvia fulva TF-13 was cultured at 25°C on potato dextrose agar (PDA) plates. The following antibiotic concentrations were used for E. coli and Burkholderia strains: ampicillin, 100 μg/ml; kanamycin, 50 μg/ml; chloramphenicol, 25 μg/ml; and trimethoprim, 50 μg/ml. To isolate antifungal activity-deficient mutants of Burkholderia, PDA was used for plate bioassays.
Transposon mutagenesis and selection of antifungal activity-deficient mutants. Transposon mutagenesis of B. pyrrocinia CH-67 was performed using the mini-Tn5 derivative plasposon in pTnMod-OTp (Dennis and Zylstra, 1998) to select mutants with altered antifungal activity.
Transposon-inserted mutants were selected by plating the exconjugants of CH-67 on M9 minimal agar containing 50 μg/ml trimethoprim. The resulting trimethoprim-resistant colonies were picked and inoculated in NB containing 50 μg/ml trimethoprim. To select mutants deficient in antifungal activity (non-antagonistic mutants), F. fulva spore solution was prepared and spread on PDA plates, and the mutant bacterial suspension was simply dropped on the PDA plate and incubated for 3-5 days at 25°C (Fig. 1) . The fungal spore suspension (1 × 10 5 conidia/ml) was prepared in sterile water from fungal cultures grown on PDA. To prepare the fungal spore suspension, F. fulva TF-13 was inoculated on PDA and incubated for 2 weeks at 25°C.
Four grown fungal discs (ø = 1 cm) were plated to 100 ml of PD broth, and the inoculum was incubated for 4 days at 25°C and 150 rpm. The culture broth was filtered through a double-layer of sterile cheesecloth to remove mycelial fragments. The conidial suspension was diluted in PD broth until A 550 = 0.4.
Bacterial mutants showing either no inhibition of fungal mycelium growth or reduced fungal growth were selected and stored at −80°C until use. Following the selection of mutants lacking antifungal activity, transposon insertion was examined using Southern hybridization. Genomic DNA from wild-type and mutant B. pyrrocinia was purified using Genomic DNA extraction kit (Cosmo, Korea), digested overnight with the appropriate restriction enzymes, fractionated on a 0.8% agarose gel, and transferred to Hybond-N+ nylon membrane (Amersham Pharmacia Biotech., Piscataway, USA) by Southern blotting (Sambrook et al., 1989) . Hybridization and detection were carried out under normal-stringency conditions using a probe DNA labeled with DIG DNA labeling and Detection Kit (Roche, Germany). The trimethoprim resistance gene (dhfr) from pTnModOTp' and a putative adenylate kinase gene were used as probes.
Gene cloning and DNA sequencing. General DNA manipulations were performed as described by Sambrook et al. (Sambrook et al., 1989) . To identify the transposon-inserted site in the CH-67 mutants, chromosomal DNA containing the transposon insertion was isolated to rescue the plasmid carrying the transposon-inserted DNA. Briefly, PstI-digested chromosomal DNA of the mutant M208, which was deficient in antifungal activity, was self-ligated with T4 DNA ligase and subsequently used to transform E. coli DH5α. Plasmid DNA was isolated from the resulting transformants, digested with PstI and analyzed by agarose gel electrophoresis. Plasmid DNAs were also used as templates in sequencing reactions with the primers PPI MB ori and Trmp F (Table 1) .
Primers for the putative adenylate kinase gene were designed based on the genomic DNA sequences flanking the transposon insertion site in the mutant M208. The adenylate kinase gene was amplified using the adenyl Pro F and adenyl R primers (Table 1 ). The PCR products were amplified from CH-67 chromosomal DNA using LA Taq DNA polymerase (Takara, Japan).
Complementation analysis of M208. Because B. pyrrocinia CH-67 was resistant to several antibiotics, it was impossible to use many of broad host range shuttle plasmids to complement the mutant M208 using original adenylate kinase gene. Therefore, we first constructed a modified broad host range plasmid using pRK415, which carries the chloramphenicol acetyltransferase gene (cat), for mutant comple- mentation. Chloramphenicol is an effective antibiotic for the CH-67 strain, thereby making cat an effective selection marker. The chloramphenicol resistance gene, cat, was amplified from the fosmid pEPI-FOS5 (Epicentre, Madison, USA) using the primers Chloram F and Chloram R (Table  1) and cloned into StuI-digested pRK415 to create pRC415 (Table 1 ). The DNA fragment containing the intact adenylate kinase gene was amplified from B. pyrrocinia CH-67 genomic DNA using the primers Adenyl Pro F and Adenyl R. The 811 bp amplified DNA included the promoter area and full coding region of the adenylate kinase gene, and was cloned into pGEM-T Easy (Promega, Madison, USA) to create pProAKR2. The 0.8 kb SphI and SpeI fragment of pProAKR2 was cloned into pUC129 to generate pAK129. Plasmid pAK129 was digested with HindIII and XbaI, and the full-length gene encoding adenylate kinase was cloned into pRC415 to create pRAK415. The complementation plasmid pRAK415 was first transformed into E. coli SM10 for subsequent transfer to the mutant M208 using a biparental mating procedure (Simon et al., 1983) . The empty vector (pRC415) was used as a control. M208 conjugants carrying pRAK415 were selected on M9 minimal medium containing trimethoprim and chloramphenicol. Complementation experiments were conducted using plate assays to evaluate antifungal activity against F. fulva.
Nucleotide sequence accession numbers. The nucleotide sequences of the pProAKR2 inserts have been deposited in GenBank under the accession numbers JQ929304.
Results

Selection of non-antagonistic mutants.
A total of 2,500 transposon-insertion mutants were screened using F. fulva to select mutants deficient in antifungal activity (Fig. 1) . A mutant, M208, deficient in antifungal activity against F. fulva was selected, while the mutant was not an auxotroph. Many of mutants showing either deficiency of antifungal activity or reduced antifungal activity appeared to be auxotrophic mutants, because they were not grown on a minimal medium M9. Growth of M208 was somewhat slower compared to that of the wild type; however, the wild-type and mutant cell numbers were not different after 48-h incubation in liquid culture such as NB (Fig. 2) . Southern blot analysis of PstI, EcoRI-digested genomic DNA of the mutant revealed a clear single hybridization signal (data not shown). This result indicated that the transposon was inserted into the mutant chromosome as a single copy, suggesting that the disrupted gene may be responsible for the antifungal activity-deficient phenotype of the selected mutant.
Identification of the transposon insertion site. Mutated genes in the M208 mutant were identified with a plasmid rescue approach using self-ligated chromosomal DNA. The plasmid pM208 was obtained from the genome of M208 using a conventional plasmid rescue method. The plasmid pM208 carried a 1.8-kb genomic DNA insert from the mutant (data not shown). The transposon-inserted region was determined by inverse PCR sequencing with the primers PPI MB ori and Trmp F using the recombinant plasmid pM208. The DNA sequences of the rescued plasmids were similar to that of genes from some Burkholderia species. The disrupted gene in M208 was similar to a gene encoding a putative adenylate kinase in B. cenocepacia MCO-3. The full-length gene for adenylate kinase was obtained by PCR from the wild-type CH-67 strain and DNA sequences of the adenylate kinase gene were determined. The deduced amino acid sequence of adenylate kinase from CH-67 was 80% identical to that from the MCO-3 strain. The gene organization flanking the adenylate kinase gene in MCO-3 indicated that the mutated gene may not be linked with other genes as an operon (data not shown). Multiple alignment of adenylate kinase from CH-67 and other bacteria revealed that the N-terminal region of the protein was conserved among the homologs (Fig. 3) .
Adenylate kinase for antifungal compound production. To determine the function of adenylate kinase in B. pyrrocinia CH-67, adenosine monophosphate (AMP), adenosine triphosphate (ATP), or adenosine diphosphate (ADP) was added to the M208 culture broth and antifungal activity was examined. Addition of AMP or ATP alone did not restore antifungal activity in the M208 mutant (Table 2) . However, the antifungal activity of M208 was restored when AMP and ATP were added together in the bacterial cultures. Addition of ADP (1 mM to 20 mM) to the M208 culture broth also restored antifungal activity ( Table 2 ). The adenylate kinase gene disrupted in the transposon mutant M208 was complemented to confirm the role of the adenylate kinase gene in antifungal metabolite production. The plasmid pRAK415, carrying the wild-type adenylate kinase gene, was introduced into the mutant M208 in trans. Mutant M208 carrying pRAK415 inhibited the growth of F. fulva as efficiently as the wild-type strain (Fig. 4) . In contrast, mutant M208 harboring the empty vector pRC415 was deficient in antifungal activity. Moreover, pRC415 did not affect antifungal activity when introduced into wild-type CH-67 (Fig. 4) . Our results suggest that adenylate kinase may be involved in antifungal activity expression in CH-67.
Discussion
Burkholderia cepacia complex (Bcc), firstly reported as a plant pathogen responsible for a bacterial rot of onions (Burkholder, 1950) , and recently it has been warned that some strains of Bcc can causes cystic fibrosis in human, and thus some Bcc considered as clinical strains. However, some soil strains in the Bcc complex have been recognized as an effective biocontrol agent and biotechnological use (Chiarini et al., 2006 ). An antagonistic bacterium B. pyrrocinia CH-67 with strong antifungal activity against many plant pathogenic fungi was previously isolated from forest soil (Lee et al., 2011) . The CH-67 strain demonstrated to belong to genomovar IX and identified as B. pyrroconia. The genomovar IX is known to be the representative genomovar containing mostly non-clinical strains of Bcc (Mahenthiralingam et al., 2005) .
To understand the molecular mechanisms underlying the antagonistic activity of B. pyrrocinia CH-67, mutagenesis and subsequent identification of the gene responsible for antifungal activity were carried out. A total of 2,500 mutants were screened using a fungal spore-based method to select non-antagonistic mutants. This method is rapid and useful to select antifungal activity-deficient mutants in a short time. The gene responsible for the antifungal activity was identified using a plasmid-rescue approach with the selected mutant. Many studies have combined transposon mutagenesis with flanking DNA sequencing of insertion sites (Hoffman et al., 2000; Horecka and Jigami, 2000; Lee et al., 2003; Ruffin et al., 2000) . This study selected only one mutant defective in antifungal activity. However, only 2,500 mutants were screened and it may be possible that more non-antagonistic mutants could be obtained by screening more mutants.
Here, a gene encoding adenylate kinase, which is associated with antifungal activity in B. pyrrocinia CH-67, was identified using the M208 mutant. Adenylate kinase plays a key role in the interconversion of the constituents of the adenine nucleoside pool, catalyzing the reversible reaction ATP + AMP to ADP (Glaser et al., 1975) . Regulation of adenylate kinase activity may provide the cell with a mechanism for controlling macromolecular biosynthesis such as membrane phospholipids and regulating cell growth (Goelz and Cronan, 1982; Huss and Glaser, 1983) . The adenylate kinase gene in this study may be involved in regulating the expression of antifungal activity. In the ATP/ ADP/AMP feeding experiment, ADP was able to restore antifungal activity in the M208 mutant, suggesting that the gene identified in this study was truly functioning as adenylate kinase and that the ATP/ADP/AMP balance may be essential for antifungal compound production. In B. pyrrocinia CH-67, adenylate kinase may control the expression of antifungal activity and may partially regulate bacterial growth rate. Inactivation of adenylate kinase (as in M208) caused a delay in initial bacterial growth. This may be due to the ATP/ADP/AMP imbalance in the adenylate kinase mutant. However, the wild-type and M208 cell numbers were not different after 48-h incubation, indicating that the antifungal activity deficiency in M208 was not due to delayed bacterial growth. The M208 mutant did not exhibit antifungal activity even after 72-h incubation. Addition of ADP or high concentrations of ATP and AMP together restored the bacterial growth rate and antifungal activity in M208, suggesting the importance of adenylate kinase in CH-67.
While many studies on adenylate kinase are mainly focused on its role in nucleotide mechanism, there are several reports on other alteration of bacterial phenotypes by inactivation of adenylate kinase other than nucleotide metabolism. Adenylate kinase has been extensively studied in E. coli and is involved in macromolecule biosynthesis and cell growth regulation (Goelz and Cronan, 1982) . It has been speculated that inactivation of adenylate kinase caused changes in the concentration of adenine nucleotides which in turn caused a defect in some macromolecular synthesis in E. coli (Goelz and Cronan, 1982) . In addition, adenlyate kinase in Yersinia pestis is involved in bacterial virulence and nucleotide metabolism since inactivation of adenylate kinase in Y. pestis was avirulent (Munier-Lehmann et al., 2003) . It is likely that nucleotide imbalance caused by adenylate kinase mutation may be responsible for many bacterial phenotypic alterations.
Introduction of the full-length adenylate kinase gene in trans in M208 completely restored the antifungal activity and initial growth rate to wild-type levels, suggesting that adenylate kinase is involved in antifungal compound production in B. pyrrocinia CH-67. However, it is not clear whether adenylate kinase directly affects antifungal compound production. Our previous attempt to fractionate the antifungal compound from CH-67 culture supernatant was unsuccessful because of poor solubility of the antifungal compound in organic solvents. Therefore, the nature of the antifungal compounds produced by the CH-67 strain remains unknown. The nucleotide imbalance in the mutant M208 may have caused an imbalance in bacterial metabolism, resulting in a dramatic reduction in the production of bacterial secondary metabolite that may possess antifungal activity. The mechanisms underlying the involvement of adenylate kinase in antifungal activity expression in B. pyrrocinia CH-67 should be further investigated. To our best knowledge, this is the first study to show that adenylate kinase is involved in antifungal activity expression in a biocontrol bacterium such as B. pyrrocinia.
